Shenzhen IBelieve Technology Co., Ltd. – Trademark Portfolio
Entity Type: 99
Shenzhen IBelieve Technology Co., Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. The portfolio also extends into Class 20 (Furniture) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include FOLEE and ABLIGOGO. The owner is based in Shenzhen.
Room 608, United Building, Donghuan 1st
Road, Longhua Subdist., Longhua Dist.
Shenzhen 518000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Shenzhen IBelieve Technology Co., Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Shenzhen IBelieve Technology Co., Ltd. have?
Shenzhen IBelieve Technology Co., Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Shenzhen IBelieve Technology Co., Ltd. file in?
Shenzhen IBelieve Technology Co., Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 20 (Furniture). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Shenzhen IBelieve Technology Co., Ltd.'s most well-known trademarks?
Shenzhen IBelieve Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as FOLEE and ABLIGOGO. These are among 2 currently registered trademarks in the portfolio.
What is Shenzhen IBelieve Technology Co., Ltd.'s trademark registration success rate?
Shenzhen IBelieve Technology Co., Ltd. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.